Gradientech logo — Precision medicine for a sustainable world.

Gradientech

Precision medicine for a sustainable world.

Founded 2009 Sweden Sweden 42 employees Series Unknown Total: $34.67M Biotechnology, Health Care +1

General Information

Company Name Gradientech
Founded Year 2009
Location Sweden Sweden +1
Employees 42
Industries Biotechnology, Health Care, Life Sciences
Funding Stage Series Unknown
Social

Get notified when Gradientech moves

Funding, new markets, leadership changes, hiring surges — one e-mail, only when something happens.

Free · no account needed

About Gradientech

Gradientech is a Swedish in vitro diagnostics company founded in 2009 that focuses on precision medicine for a sustainable world. The company's flagship product, QuickMIC®, is aimed at supporting modern microbiology labs by providing ultra-rapid antibiotic susceptibility testing (AST) for time-critical samples such as positive blood culture samples from sepsis patients. This scalable system, with each instrument analyzing one sample against a tailored gram-negative antibiotic panel, can deliver MIC values in as short as 2 hours, making it faster than any other diagnostic system for phenotypic AST. Gradientech's technology, which integrates microfluidics with live imaging to analyze bacterial responses on a linear antibiotic concentration gradient, provides MIC values with unprecedented precision in record time. The company operates within the Biotechnology and Health Care industries, with headquarters in Sweden. In April 2019, Gradientech secured a $4.60M Venture Round investment, demonstrating investor confidence in the company's innovative solutions for rapid and precise AST in complex clinical scenarios.

Taxonomy: Precision medicine, Biotech, Diagnostics, Microbiology, Antibiotic susceptibility testing, Medical technology, Sepsis, Blood culture samples, Microfluidics, Live cell imaging, ISO13485 certification

Funding Rounds & Investors (5)

View All
Funding Stage Amount Investors Lead Investors Date
Venture Round •••••• - 04 Apr 2019
Venture Round •••••• 1
Investor
13 Sep 2018
Grant •••••• 1 •••• •••• 01 Apr 2018
Venture Round •••••• 1
Investor
09 Dec 2016
Venture Round •••••• 1
Investor
01 Jan 2011

Gradientech Alternatives & Competitors

Gradientech vs
Acenxion Biosystems
Acenxion Biosystems United States

Phenotypic AST results, in hours.

Seed
11 employees
Biotechnology, Life Sciences
Gradientech vs

Avails Medical, Inc. - Affordable & Rapid Antibiotic Susceptibility Testing for clinical laboratorie...

Grant
51 employees
Health Care, Medical Devices
Gradientech vs
Pattern Bioscience
Pattern Bioscience United States

Our mission is simple: We will improve the world's most important health decisions.

Series C
76 employees
Biotechnology, Health Care

FAQ About Gradientech

Precision medicine for a sustainable world.
Gradientech was founded in 2009.
Gradientech is headquartered in Sweden.
Gradientech operates in the following industries: Biotechnology, Health Care, Life Sciences.
Gradientech has approximately 42 employees.
Gradientech has completed 5 funding rounds, raising a total of $34.67M. The latest funding stage is Series Unknown.
Top alternatives and competitors to Gradientech include Acenxion Biosystems, Avails Medical, Inc., Pattern Bioscience, AdvanDx, AST . These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Gradientech and Acenxion Biosystems are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Don't just browse. Track.

Signal Tracker monitors Gradientech and millions of companies for funding rounds, hiring surges, product changes, and 40+ signal types — so you never miss an opportunity.

One analytics cookie (Google Analytics). Cookie Policy